EDITORIAL
Published on 18 Jul 2022
Editorial: Chronic Liver Disease: New Targets and New Mechanisms
doi 10.3389/fmolb.2022.963630
- 1,832 views
- 1 citation
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Chronic Liver Disease: New Targets and New Mechanisms
Chronic Liver Disease: New Targets and New Mechanisms
26k
Total downloads
94k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 03 Feb 2022
Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
doi 10.3389/fmolb.2021.802251
- 3,409 views
- 7 citations
REVIEW
Published on 31 Jan 2022
ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets
doi 10.3389/fmolb.2021.804097
- 4,613 views
- 6 citations
REVIEW
Published on 11 Jan 2022
Nanotechnology in Drug Delivery for Liver Fibrosis
doi 10.3389/fmolb.2021.804396
- 8,658 views
- 34 citations
REVIEW
Published on 07 Jan 2022
HSD17B13: A Potential Therapeutic Target for NAFLD
doi 10.3389/fmolb.2021.824776
- 15,320 views
- 27 citations
REVIEW
Published on 24 Dec 2021
Beyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects
doi 10.3389/fmolb.2021.823277
- 29,611 views
- 16 citations
REVIEW
Published on 21 Dec 2021
Biliary Epithelial Senescence in Liver Disease: There Will Be SASP
doi 10.3389/fmolb.2021.803098
- 6,158 views
- 20 citations
REVIEW
Published on 13 Dec 2021
The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
doi 10.3389/fmolb.2021.790032
- 2,939 views
- 12 citations
REVIEW
Published on 02 Dec 2021
Cytokines and Chemokines in HBV Infection
doi 10.3389/fmolb.2021.805625
- 7,418 views
- 38 citations
REVIEW
Published on 24 Nov 2021
The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
doi 10.3389/fmolb.2021.792667
- 5,546 views
- 17 citations
ORIGINAL RESEARCH
Published on 16 Nov 2021
Potential Molecular Targets of Tenofovir Disoproxil Fumarate for Alleviating Chronic Liver Diseases via a Non-Antiviral Effect in a Normal Mouse Model
doi 10.3389/fmolb.2021.763150
- 2,733 views
- 9 citations
REVIEW
Published on 05 Nov 2021
Novel Therapeutic Targets in Liver Fibrosis
doi 10.3389/fmolb.2021.766855
- 7,137 views
- 25 citations
Published in
Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
Impact
- 94kTopic views
- 66kArticle views
- 26kArticle downloads